{"id":118,"date":"2026-07-16T06:00:12","date_gmt":"2026-07-16T06:00:12","guid":{"rendered":"https:\/\/dentaltransitions.sites.aigrowthagent.co\/dso-offer-comparison-dental-practice\/"},"modified":"2026-07-16T06:00:12","modified_gmt":"2026-07-16T06:00:12","slug":"dso-offer-comparison-dental-practice","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dso-offer-comparison-dental-practice\/","title":{"rendered":"How to Compare DSO Offers for Your Dental Practice"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li>\n<p>Headline price alone can mislead. True value depends on cash at close, earnout probability, rollover equity structure, and tax treatment.<\/p>\n<\/li>\n<li>\n<p>A disciplined comparison uses a 13-metric framework covering compensation, non-competes, working-capital adjustments, and buyer financial health.<\/p>\n<\/li>\n<li>\n<p>Creating competition through a structured bid process can improve total transaction value over an unsolicited offer.<\/p>\n<\/li>\n<li>\n<p>Red flags such as undercapitalized platforms, punitive earnouts, and overly broad non-competes can erode expected proceeds and post-close experience.<\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">A confidential discovery call with McLerran can help you review your offers and plan your next step.<\/a><\/p>\n<\/li>\n<\/ul>\n<h2>Headline Price Does Not Tell the Full Story<\/h2>\n<p>Headline price is enterprise value. It&#8217;s the total consideration a buyer proposes before deductions, contingencies, or tax treatment enter the picture. What you actually receive is different: after-tax, risk-adjusted proceeds spread across cash at close, rollover equity (an ownership stake you retain in the acquiring platform), and earnouts (contingent payments tied to post-close performance targets).<\/p>\n<p>In recent DSO dental deals, a significant portion of the headline price is guaranteed cash at close. The remainder splits between earnouts over 12 to 36 months and rollover equity that can stay illiquid for 5 to 7 years. Two offers at the same headline multiple can produce very different net proceeds once you account for how much is cash, how much is contingent, and how the IRS treats each piece.<\/p>\n<p>The current market adds complexity. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.thesorso.com\/answers\/dental-practice-ebitda-multiple\">Multi-location groups with $1.0M to $3.0M in adjusted EBITDA have traded in a 7x to 9x adjusted EBITDA band in recent periods<\/a> (earnings before interest, taxes, depreciation, and amortization, the standard profitability measure DSOs use to value practices). <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.thesorso.com\/answers\/dental-practice-ebitda-multiple\">Platform-tier groups with $5M or greater adjusted EBITDA have traded in a 10.0x to 12.0x band<\/a>, and specialty practices can command different ranges. The specific number matters less than this: two offers at similar multiples can look very different once structure, tax treatment, and post-close obligations are mapped side by side.<\/p>\n<p>That mapping is what a professional DSO offer comparison is built to do, and it&#8217;s the framework covered next.<\/p>\n<h2>The 13 Metrics That Separate a Good Offer From a Weak One<\/h2>\n<p>The table below lists 13 metrics that can determine which offer is actually superior. Every data point in a real comparison should come from the buyer&#8217;s letter of intent (LOI) and supporting materials, then get stress-tested by an advisor.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Metric<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>What to Measure<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Why It Matters<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Cash at close<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Guaranteed dollars paid on closing day as a percentage of headline price<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Only cash at close is guaranteed; earnouts and rollover equity are probabilistic<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Equity percentage and level<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Rollover equity as a share of total consideration; held at joint-venture (practice-level) or holding-company (platform-level) tier<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>JV equity often pays distributions but has a lower ceiling; holdco equity offers higher upside with no distributions and more illiquidity risk<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Earnout structure and probability<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Size, duration (12 to 36 months is typical), metrics, and whether payouts are linear (pro-rata) or cliff-based<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/is-your-dso-offer-fair\">Earnout realization rates in DSO dental transactions can vary; sellers should assume a moderate realization probability unless evidence supports higher<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Post-close compensation<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Annual salary or production percentage during the required employment term, compared to current owner take-home<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/is-your-dso-offer-fair\">DSO employment commitments typically run 2 to 5 years at clinical compensation below prior take-home, creating an annual cost<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Non-compete scope<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Duration, geographic radius, and activity definition (general dentistry vs. all dental services)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>DSO buyers often propose non-competes of 2 to 5 years and a 5 to 15 mile radius<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Change-of-control protections<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>What happens to your earnout and equity if the DSO is sold or recapitalized during your employment term<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Without acceleration clauses, a mid-term DSO sale can leave earnout payments in limbo<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Working-capital adjustments<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>How the buyer defines cash, accounts receivable, supplies, and prepaid expenses at closing<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Working capital true-up adjustments can cost sellers when the purchase agreement uses unfavorable definitions<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Tax treatment<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Allocation of purchase price between goodwill (typically long-term capital gains) and employment or consulting agreements (ordinary income)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/is-your-dso-offer-fair\">DSO offers can allocate more of total proceeds to ordinary-income categories than internal sales, which reduces after-tax proceeds<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Recapitalization assumptions<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>The buyer&#8217;s projected timeline and multiple for its next platform sale (the event that converts your rollover equity to cash)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/groupdentistrynow.com\/dso-group-blog\/dso-mergers-acquisition\">Many dentists rolled over equity expecting a second transaction within three to five years, but recapitalization delays have postponed these payouts<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Buyer financial health<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Platform profitability, debt load, same-store revenue growth, and private equity backer track record<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>An undercapitalized DSO puts a large share of your equity and earnout proceeds at risk<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Management-team track record<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Leadership experience, history of successful recapitalizations, and seller satisfaction at acquired practices<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>You are becoming a minority investor in this platform, so it deserves the same scrutiny<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Post-close support model<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>What the DSO will actually provide: HR, payroll, IT, compliance, marketing, and growth infrastructure<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Support quality affects your post-close production and, in turn, your earnout realization<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Staff and patient continuity commitments<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Written protections for staff retention and patient communication protocols<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Weak transition planning can raise patient attrition after a sale, while a properly structured transition can help retain patients<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Each row on its own tells you little. Read together, they show whether an offer&#8217;s real value matches its headline number, and that comparison sets up the four-step process below.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Get your current offers scored against this framework<\/strong> on a confidential call with McLerran &amp; Associates.<\/a><\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Step 1: Map Every Option, Including Staying Put<\/h2>\n<p>The first step in any rigorous DSO offer comparison is building a complete picture of what&#8217;s actually available, including the option of doing nothing.<\/p>\n<p>Required inputs at this stage include any LOIs already received, three years of tax returns and practice management reports, and a diligence-grade EBITDA analysis. That last item matters most. Many lower-middle-market deals undergo retrading after LOI, with Quality of Earnings findings among the primary triggers. Buyers who find weaknesses in your numbers will push the price down after you&#8217;ve already agreed to terms. A CPA-led EBITDA analysis done before you go to market controls that narrative from the start.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p>The key decision here is whether your practice fits a DSO affiliation, a doctor-to-doctor sale, or continued independent ownership. McLerran &amp; Associates works both transition paths in roughly equal measure, with approximately 2,000 successful practice sales and close to $2 billion in closed transaction volume. That balance lets the firm deliver a genuine side-by-side valuation quantifying your worth in both markets, something single-lane brokers cannot provide. With that valuation in hand, the next move is turning a single offer into real competition.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<h2>Step 2: Turn One Offer Into a Real Market<\/h2>\n<p>A single DSO offer, however attractive, is not a market. It&#8217;s one buyer&#8217;s opening position. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/is-your-dso-offer-fair\">DSO opening offers can run below best-and-final on practices that proceed to multi-bid processes<\/a>. A competitive sales process for dental practices can improve total transaction value over an unsolicited offer.<\/p>\n<p>Creating competition requires a vetted buyer pool, a structured bid process, and the discipline to run it on your timeline. McLerran &amp; Associates typically generates around 10 offers per listing through a 45 to 60-day process, and has blacklisted DSOs known for poor post-close environments so weak buyers never reach the table.<\/p>\n<p>The trade-off here is time and confidentiality. A well-run process protects both. Buyers sign NDAs before receiving any practice information, and the process is built to close within a defined window rather than drag on indefinitely.<\/p>\n<h2>Step 3: Pick the Buyer, Not Just the Bid<\/h2>\n<p>Once competing bids are on the table, the highest number isn&#8217;t automatically the right buyer. This step narrows the field from multiple offers to one or two finalists whose strategy, support model, and culture match what you want for your practice after you walk away.<\/p>\n<p>Required inputs include the buyer&#8217;s audited financials or investor materials, references from previously acquired practices, and a clear picture of their post-close support model. In-person meetings or headquarters visits with finalists are standard here.<\/p>\n<p>The central trade-off is price versus fit. A buyer offering a slightly lower headline number but stronger post-close infrastructure, a more experienced management team, and a realistic recapitalization timeline may produce a better net outcome over the full hold period than the highest bidder with a weaker platform. Once you&#8217;ve chosen a finalist, the negotiation itself determines how much of that value you actually keep.<\/p>\n<h2>Step 4: Negotiate the Terms That Protect Your Payout<\/h2>\n<p>Once a preferred buyer is identified, the work shifts to LOI negotiation and deal structuring. Every metric in the comparison table above is a negotiating lever. Earnout and rollover terms are set in the LOI, where DSO teams hold a leverage advantage; negotiating structure after signing reduces seller leverage significantly.<\/p>\n<p>Negotiation priorities follow directly from the red flags covered later in this article. Pushing for linear, pro-rata earnout payouts instead of cliff structures prevents the shortfalls that cliff-based targets can create. Locking expense allocations closes the loophole that lets a DSO shift overhead into your earnout calculation. Securing acceleration clauses protects those same earnout dollars if the DSO sells mid-term. Negotiating non-compete geography and duration down to market norms addresses the overly broad restrictions many DSOs propose upfront.<\/p>\n<h3>Hypothetical Example: $2M Revenue Practice<\/h3>\n<p>Consider a hypothetical general dental practice generating $2M in annual collections with $400K in adjusted EBITDA. Two DSOs submit offers. The multiples and figures below are illustrative only, not sourced benchmarks, and don&#8217;t represent guaranteed outcomes for any specific practice.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Metric<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Offer A<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Offer B<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Headline price<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$2.8M (7x EBITDA)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$2.4M (6x EBITDA)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Cash at close<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$1.68M (60%)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$1.92M (80%)<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Rollover equity<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$840K (30%), holdco level, illiquid 5 to 7 years<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$360K (15%), JV level, distributions paid annually<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Earnout<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$280K (10%) over 36 months, cliff-based targets<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$120K (5%) over 12 months, pro-rata structure<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Post-close compensation<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$220K per year for 5 years<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$280K per year for 3 years<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Non-compete<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>5 years, 20-mile radius<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>2 years, 10-mile radius<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Tax allocation (goodwill vs. ordinary income)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>65% goodwill \/ 35% ordinary income<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>80% goodwill \/ 20% ordinary income<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Buyer financial health<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Moderate debt load, no completed recapitalization<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Strong balance sheet, one prior successful recap<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Offer A&#8217;s headline price is higher. Offer B delivers more guaranteed cash at close, a shorter and less restrictive non-compete, more annual compensation over a shorter employment term, a more favorable tax allocation, and a buyer with a proven recapitalization track record. On a risk-adjusted, after-tax basis, Offer B may produce a superior net outcome despite the lower headline number. This is exactly what a professional DSO offer comparison is designed to surface, and it&#8217;s also where red flags start to show up.<\/p>\n<h2>Warning Signs That Can Erode Your Deal<\/h2>\n<p>Not every DSO makes a good partner. These warning signs can point to a buyer who underdelivers on the non-cash parts of your deal or creates a difficult post-close environment.<\/p>\n<ul>\n<li>\n<p><strong>Undercapitalized platforms.<\/strong> <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/groupdentistrynow.com\/dso-group-blog\/dso-mergers-acquisition\">The higher cost of capital since late 2022 has forced some DSOs to manage large debt loads, leading to layoffs, restructuring, or lender takeovers.<\/a> A DSO that cannot service its debt cannot fund your earnout or deliver a successful recapitalization.<\/p>\n<\/li>\n<li>\n<p><strong>Punitive earnout structures.<\/strong> Cliff-based targets, broad DSO discretion over expense allocations, and no acceleration clause on change of control all reduce your probability of full payout. Earnouts in dental DSO deals can underperform because buyers can influence metrics by adding expenses to the P&amp;L or making operational changes that reduce production.<\/p>\n<\/li>\n<li>\n<p><strong>Vague equity rights.<\/strong> Not all equity rollover is created equal. The terms matter enormously, so understand the preferred vs. common equity structure and ask about the DSO&#8217;s recapitalization timeline. Rollover equity without tag-along rights, anti-dilution protections, or information rights is a speculative instrument, not deferred cash.<\/p>\n<\/li>\n<li>\n<p><strong>Overly broad non-competes.<\/strong> DSO contracts often define the restricted area as a radius around every DSO location rather than only the seller&#8217;s original practice, which can block a dentist from working anywhere in a metro region.<\/p>\n<\/li>\n<li>\n<p><strong>Pressure to close without seller due diligence.<\/strong> A buyer who discourages you from having your own advisor review the LOI benefits from your information disadvantage.<\/p>\n<\/li>\n<\/ul>\n<p>These same issues, cash flow strain, earnout traps, thin equity protections, and broad non-competes, are the exact points a well-run comparison and negotiation process is meant to catch before you sign. The FAQs below cover the questions dentists ask most often once they start weighing these details.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Have your current offers checked against these red flags<\/strong> on a confidential call with McLerran &amp; Associates before you sign anything.<\/a><\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>When is the right time to sell my dental practice to a DSO?<\/h3>\n<p>There is no universal answer, but several factors can make the timing favorable. Demand for premier practices remains strong in 2026, and valuations for well-prepared practices sit near historical highs. From a tax perspective, provisions affecting capital gains rates are subject to legislative change, which can create urgency for owners who are otherwise ready to transact. On the personal side, the right time is when your reason for selling is clear, whether that&#8217;s taking chips off the table, gaining operational support, or starting a transition toward reduced clinical hours. McLerran &amp; Associates will tell you candidly how your practice is positioned and, if you&#8217;re not ready, will update your valuation at no charge a year later rather than push you into a deal early.<\/p>\n<h3>How are earnouts and rollover equity taxed in a DSO deal?<\/h3>\n<p>Tax treatment in a DSO transaction depends heavily on how the purchase price is allocated between asset categories. Proceeds allocated to goodwill, typically the largest component of a dental practice sale, are generally taxed at long-term capital gains rates, which are lower than ordinary income rates. Proceeds allocated to employment agreements, consulting agreements, or non-compete payments are generally taxed as ordinary income. Rollover equity isn&#8217;t taxed at close; it becomes taxable when you eventually sell or exchange those units, typically at the DSO&#8217;s next recapitalization. Earnout payments are taxed in the year received, at rates that depend on how the payment is characterized in the purchase agreement. As noted earlier, DSO offers tend to skew toward ordinary-income allocations, so the specific tax allocation in your LOI can meaningfully affect your after-tax outcome. Always consult a qualified CPA or tax attorney before signing anything. This is education, not tax advice.<\/p>\n<h3>How often should I update my practice valuation, and does it change my negotiating position?<\/h3>\n<p>Update your valuation any time there&#8217;s a material change in your financials, such as a significant revenue increase, an added associate, a shift in payer mix, or a major equipment investment. As a baseline, an annual update is reasonable for any owner actively considering a transition within three to five years. Valuation affects your negotiating position because it establishes the narrative around your EBITDA before buyers get a chance to set their own anchor number. A diligence-grade, CPA-led valuation done before you go to market is one of the most effective ways to prevent post-LOI retrading, where buyers use Quality of Earnings findings to push the price down after terms are agreed. McLerran &amp; Associates builds this analysis up front and updates it at no charge for clients who aren&#8217;t yet ready to transact.<\/p>\n<h3>What is the difference between JV-level equity and holding-company equity in a DSO deal?<\/h3>\n<p>In a joint-venture (JV) structure, you retain an ownership stake in your specific practice location rather than the broader DSO platform. JV equity typically pays ongoing distributions from your practice&#8217;s profits, giving you a more predictable income stream during your employment term. The ceiling on JV equity appreciation is generally lower, though, since it&#8217;s tied to one location rather than the growth of the entire platform. Holding-company equity gives you a stake in the DSO&#8217;s parent entity. It doesn&#8217;t typically pay distributions, so you receive no cash from it until the platform is sold or recapitalized, which can be 5 to 7 years away. The potential upside is higher if the platform performs well, but the risk is higher too: the equity is illiquid, junior to platform debt, and its value depends on factors outside your control. Understanding which level your rollover equity sits at, and what governance rights come with it, is one of the most important questions to resolve before signing an LOI.<\/p>\n<h2>Putting the Framework to Work<\/h2>\n<p>A DSO offer comparison for your dental practice isn&#8217;t a simple exercise in ranking headline prices. It&#8217;s a structured analysis of 13 interconnected metrics, cash at close, equity structure, earnout probability, post-close compensation, non-compete scope, and buyer quality among them, that together determine what you actually walk away with after taxes, after contingencies, and after the employment term you&#8217;re committing to.<\/p>\n<p>McLerran &amp; Associates&#8217; track record, cited earlier, combined with a transaction rate of roughly 85 to 90% (versus an industry norm closer to 35 to 40%), means clients see the real market rather than a single buyer&#8217;s opening position. The firm works both the private-buyer and DSO paths in roughly equal measure, runs a structured competitive bid process that typically generates around 10 offers per listing, and has blacklisted DSOs known for poor post-close environments.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Find out what your specific offers reveal<\/strong> on a confidential discovery call with McLerran &amp; Associates.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Don&#8217;t judge a DSO offer by headline price alone. McLerran&#8217;s 13-metric framework helps you compare cash, equity, and terms to maximize your sale.<\/p>\n","protected":false},"author":1,"featured_media":117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=118"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/118\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/117"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}